400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / GPCR/G Protein / LPL Receptor / GSK2018682
CAS No.: 1034688-30-6
Synonyms: 2018682
GSK-2018682 is a sphingosine 1 phosphate receptor (S1PR)-1 agonist potentially for the treatment of multiple sclerosis. GSK-2018682 induced acute, transient and non-symptomatic decreases in heart rate and blood pressure.
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT01431937 | Multiple Sclerosis, Relapsing-... more >>Remitting Collapse << | Phase 1 | Completed | - | Australia, New South Wales ... more >> GSK Investigational Site Randwick, New South Wales, Australia, 2031 Australia, South Australia GSK Investigational Site Adelaide, South Australia, Australia, 5000 Australia, Western Australia GSK Investigational Site Nedlands, Western Australia, Australia, 6009 Collapse << |
NCT01387217 | Multiple Sclerosis | Phase 1 | Completed | - | Australia, New South Wales ... more >> GSK Investigational Site Randwick, New South Wales, Australia, 2031 Australia, South Australia GSK Investigational Site Adelaide, South Australia, Australia, 5000 Collapse << |
NCT01466322 | Multiple Sclerosis, Relapsing-... more >>Remitting Collapse << | Phase 1 | Completed | - | Australia, Queensland ... more >> GSK Investigational Site Herston, Queensland, Australia, 4006 Collapse << |
实验方案
技术信息
CAS号 | 1034688-30-6 | 储存条件 |
|
|||||
分子式 | C22H21ClN4O4 | 运输 | 蓝冰 | |||||
分子量 | 440.88 | 别名 | 2018682 | |||||
溶解度 |
|
动物实验配方 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT01431937 | Multiple Sclerosis, Relapsing-... more >>Remitting Collapse << | Phase 1 | Completed | - | Australia, New South Wales ... more >> GSK Investigational Site Randwick, New South Wales, Australia, 2031 Australia, South Australia GSK Investigational Site Adelaide, South Australia, Australia, 5000 Australia, Western Australia GSK Investigational Site Nedlands, Western Australia, Australia, 6009 Collapse << |
NCT01387217 | Multiple Sclerosis | Phase 1 | Completed | - | Australia, New South Wales ... more >> GSK Investigational Site Randwick, New South Wales, Australia, 2031 Australia, South Australia GSK Investigational Site Adelaide, South Australia, Australia, 5000 Collapse << |
NCT01466322 | Multiple Sclerosis, Relapsing-... more >>Remitting Collapse << | Phase 1 | Completed | - | Australia, Queensland ... more >> GSK Investigational Site Herston, Queensland, Australia, 4006 Collapse << |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网